CDVZX | VIVAX | CDVZX / VIVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 14 years | 32 years | - |
Gain YTD | 4.385 | 3.966 | 111% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 3000 | 67% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.53B | 184B | 1% |
Annual Yield % from dividends | 1.73 | 2.25 | 77% |
Returns for 1 year | 11.77 | 17.27 | 68% |
Returns for 3 years | 7.59 | 22.82 | 33% |
Returns for 5 years | 27.02 | 47.22 | 57% |
Returns for 10 years | 35.70 | 110.28 | 32% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HCACX | 25.62 | 0.11 | +0.43% |
Hartford Capital Appreciation C | |||
UIPMX | 21.40 | 0.03 | +0.14% |
Victory Precious Metals & Minerals Instl | |||
WLCVX | 21.88 | N/A | N/A |
Wilshire Large Company Value Instl | |||
FIJYX | 29.17 | -0.15 | -0.51% |
Fidelity Advisor Biotechnology Z | |||
FEREX | 10.71 | -0.10 | -0.93% |
First Eagle Global Real Assets I |